Updates to our Terms of Use

We are updating our Terms of Use. Please carefully review the updated Terms before proceeding to our website.

Monday, March 18, 2024 | Back issues
Courthouse News Service Courthouse News Service

Retrophin Inc. v. Questcor Pharmaceuticals Inc.

Questcor's unlawful acquisition of the rights to the drug Synacthen has entrenched its monopoly, Retrophin claims.

Categories / Uncategorized

Subscribe to Closing Arguments

Sign up for new weekly newsletter Closing Arguments to get the latest about ongoing trials, major litigation and hot cases and rulings in courthouses around the U.S. and the world.

Loading...